Moreover, increased expression of CD36 can also promote TAMs to ingest fatty acids and promote tumor development, so CD36 inhibitors can hinder the intake of fatty acids by TAMs and inhibit the negative impact of TAMs on immune response, ultimately achieving the purpose of inhibiting tumor progression (43). This evidence concerns the gene CD36 and neoplasm.